MDS-PAS Congress 2026 Session Evaluation - Session 1203

  • MDS-PAS Congress 2026 Session 1203 Evaluation Form

  • Parallel Session 1203

    Huntington's Disease and the Secondary Choreas

    February 13, 2026

    14:30 - 16:30

  • Learning Objectives:

    1. Describe the epidemiology of Huntington's disease in the Americas
    2. Discuss the current advances in the development of fluid biomarkers for Huntington's disease diagnosis and monitoring
    3. Identify clinical clues for the etiological diagnosis of secondary choreas

  • Session Evaluation

  • The session met its learning objectives
  • The content is relevant to my professional and / or scientific interests.
  • The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.
  • The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.
  • The overall session organization was satisfactory and appropriate.
  • I would recommend this session to a colleague.

  • Faculty Assessment

  • Alex Medina

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Eilrayna Gelyana

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Monica Haddad

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.
  • The following category best describes your current major professional activity (choose one):

  • Should be Empty: